VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1811321
Sex: F
Age:
State: IL

Vax Date: 04/03/2021
Onset Date: 04/03/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Burning feeling on top of tongue; Tingling in feet up to ankles/ hands up to elbows; Burning in feet up to ankles,/burning in hands up to elbows; Significantly increased tinnitus; Nausea; Lack of appetite; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the right arm on 03Apr2021 at 09:30 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. Medical history included shellfish allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included estrogens conjugated / medroxyprogesterone acetate (PREMPRO) for an unknown indication from an unknown date and unknown if ongoing. The patient previously took acetylsalicylic acid (ASPIRIN) for an unknown indication on an unknown date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the right arm on 13Mar2021 at 11:15 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. On 03Apr2021 at 05:00, the patient experienced burning/tingling in feet up to ankles, tingling/burning in hands up to elbows, burning feeling on top of tongue, significantly increased tinnitus, nausea and lack of appetite. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient was not tested for COVID-19. The clinical outcome of the events burning/tingling in feet up to ankles, tingling/burning in hands up to elbows, burning feeling on top of tongue, significantly increased tinnitus, nausea, lack of appetite was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: PREMPRO

Current Illness:

ID: 1811322
Sex: F
Age:
State: FL

Vax Date: 04/20/2021
Onset Date: 04/21/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Hot flashes; Fever; Headache; Jaw pain; Arm soreness; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 20Apr2021 at 10:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included anxiety and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included cannabis sativa (MARIJUANA); from unknown date for unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 30Mar2021 at 14:30 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021, the patient experienced hot flashes, fever, headache, jaw pain and arm soreness. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events hot flashes, fever, headache, jaw pain and arm soreness was not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: MARIJUANA

Current Illness:

ID: 1811323
Sex: F
Age:
State: OH

Vax Date: 04/08/2021
Onset Date: 04/22/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: I'm dizzy and nauseous anytime I'm standing; I was pretty much in pain and sleeping for four days; I was pretty much in pain and sleeping for four days; My cramps are particularly horrible and weirder still; I'm dizzy and nauseous anytime I'm standing; I'm also having diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 08Apr2021 at 14:30 (at the age of 38-years-old), as a single dose for COVID-19 immunisation. Medical history included attention deficit hyperactivity disorder (ADHD), asthma, depression and anxiety. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received medications (unspecified) within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 6955) via an unspecified route of administration in the left arm on 19Mar2021 at 12:15 (at the age of 38-years-old), as a single dose for COVID-19 immunisation. On 22Apr2021 at 14:00, the patient had an incredibly hard time with the vaccine itself, she was pretty much in pain and sleeping for four days, but her biggest problem was now she had her first period since the second shot and her cramps were particularly horrible and weirder still, she was dizzy and nauseous anytime when she was standing. The patient also had diarrhea. It's been about three days and she was still experiencing those horrible period symptoms. The patient had pretty bad cramps normally but the dizziness and nausea were new. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events she was dizzy and nauseous anytime she was standing, she was pretty much in pain and sleeping for four days, her cramps were particularly horrible and weirder still and the patient also had diarrhea was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811324
Sex: F
Age:
State:

Vax Date: 04/22/2021
Onset Date: 04/23/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: The day following my second dose i had fever; Body aches; Swollen lymph nodes; Fatigue; The night of the day after the vaccine my injection site began to swell and turn red; The night of the day after the vaccine my injection site began to swell and turn red; This is a spontaneous report from a contactable other healthcare professional, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 22Apr2021 at 15:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included sulfa allergy. The patient had unspecified known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included montelukast sodium (SINGULAIR); taken daily for allergies from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 02Apr2021 at 15:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. On 23Apr2021 at 08:00, the day following her second dose, she had experienced fever, body aches, swollen lymph nodes and fatigue. On 23Apr2021, the night of the day after the vaccine her injection site began to swell and turned red. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events reported. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, body aches, swollen lymph nodes, fatigue and the night of the day after the vaccine her injection site began to swell and turn red was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: SINGULAIR

Current Illness:

ID: 1811325
Sex: M
Age:
State: OK

Vax Date: 04/01/2021
Onset Date: 04/01/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Rash on top of both feet after both shots 1 & 2; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021 at 15:00 (at the age of 57-years-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021 as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 21:00, (after both shots 1 and 2), the patient experienced rash on top of both feet. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event rash on top of both feet after both shots 1 and 2 was recovered on an unknown date in Apr2021. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811326
Sex: M
Age:
State:

Vax Date: 04/23/2021
Onset Date: 04/23/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Left arm sore and swollen; Left arm sore and swollen; Headache; Fatigue; Sore muscles; Nausea; Fever; Chills; Cold sweats; This is a spontaneous report from a non-contactable consumer, the patient. A 27-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 23Apr2021 at 09:15 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 02Apr2021 at 09:15 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. On 23Apr2021 at 15:30, the patient experienced left arm sore and swollen, headache, fatigue, sore muscles, nausea, fever, chills and cold sweats. The events did not result in doctor or other healthcare professional office/clinic visit/emergency visit. Therapeutic measures were not taken as a result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events left arm sore and swollen, headache, fatigue, sore muscles, nausea, fever, chills and cold sweats were recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1811327
Sex: F
Age:
State: CA

Vax Date: 04/09/2021
Onset Date: 04/10/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Pain in my right knee not going away; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 09Apr2021 at 09:30 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 19Mar2021 at 09:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. On 10Apr2021, the patient experienced pain in right knee which was not going away. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event pain in right knee not going away was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811328
Sex: F
Age:
State: CA

Vax Date: 04/18/2021
Onset Date: 04/19/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: Had a genital herpes outbreak that started next day. I've only had one previously about 10 years ago.; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 18Apr2021 at 14:45 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included genital herpes 10 years ago. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had a genital herpes outbreak that started next day on 19Apr2021. The patient only had one previously about 10 years ago. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event had a genital herpes outbreak that started next day was resolving at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811329
Sex: F
Age:
State: AL

Vax Date: 04/23/2021
Onset Date: 04/24/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Tired; Sluggish; Fever; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 23Apr2021 at 12:30 (at the age of 41-year-old), as a single dose for COVID-19 immunisation. Medical history included attention deficit hyperactivity disorder (ADHD) and anxiety. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included lisdexamfetamine mesilate (VYVANSE) and venlafaxine hydrochloride (EFFEXOR); both for unknown indication from unknown date and unknown if ongoing. The patient previously received ciprofloxacin (CIPRO) and morphine (MANUFACTURER UNKNOWN); both for unspecified indication from unknown date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02Apr2021 at 12:30 (at the age of 41-year-old), as a single dose for COVID-19 immunisation. On 24Apr2021 at 10:30, the patient felt tired, sluggish and had fever. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tired, sluggish, fever was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VYVANSE; EFFEXOR.

Current Illness:

ID: 1811330
Sex: F
Age:
State: NJ

Vax Date: 04/24/2021
Onset Date: 04/24/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: I had some dry blood in my nose in the morning before vaccination as well, but 3 hrs after vaccination, my nose started bleeding; I had some dry blood in my nose in the morning before vaccination as well, but 3 hrs after vaccination, my nose started bleeding; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on 24Apr2021 at 01:30 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included some dry blood in nose in the morning before vaccination. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any concomitant medications. On 24Apr2021 at 04:30, 3 hours after vaccination, the patient's nose started bleeding. The patient had some dry blood in nose in the morning before vaccination as well. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event had some dry blood in nose in the morning before vaccination as well, but 3 hours after vaccination, nose started bleeding was unknown at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811331
Sex: M
Age:
State: CA

Vax Date: 03/03/2021
Onset Date: 03/07/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Severe cramping in both calf muscles; Cannot sprint, jog, or run; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the right arm on 03Mar2021 at 16:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. On 07Mar2021 at 15:00, 4 days after the vaccine the patient suffered severe cramping in both calf muscles while playing basketball. The patient was playing basketball every day and now cannot sprint, jog, or run since March 7th. 24 hours a day, the patient had constant muscle spasms in calves. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with physical therapy with no positive result. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe cramping in both calf muscles and now cannot sprint, jog or run was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811332
Sex: F
Age:
State: NC

Vax Date: 04/20/2021
Onset Date: 04/20/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Sore at site; Redness at site; Swelling hard tissue at site; Feeling periodic itching at site of injection; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 20Apr2021 at 10:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history (reported as not applicable). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) and atorvastatin (MANUFACTURER UNKNOWN) for unknown indications, from unknown dates and unknown if ongoing. On 20Apr2021, the patient experienced sore, redness, swelling hard tissue at site and felt periodic itching at site of injection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events sore, redness, swelling hard tissue at site and felt periodic itching at site of injection were not recovered at the time of report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: LISINOPRIL; ATORVASTATIN

Current Illness:

ID: 1811333
Sex: F
Age:
State: OH

Vax Date: 04/23/2021
Onset Date: 04/23/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: This is a spontaneous report from a noncontactable consumer (patient). A 39-year-old (non-pregnant) female patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EW0164), at the age of 39, via an unspecified route of administration, in the left arm, on Apr 23, 2021, at 10:30, single dose, for COVID-19 immunisation. No medical history provided. The patient has no known allergies. Prior to the vaccination, patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# ER8734), at the age of 39, via an unspecified route of administration, in the left arm, on Apr 2, 2021, at 10:30, single dose, for COVID-19 immunisation. On Apr 23, 2021, at 23:00 (overnight after receiving the second dose of vaccine), patient had restless legs all night. The patient never experienced restless legs previously. All night they felt itchy, tingly and weak when she tried to walk. Therapeutic measures were not taken as a result of the event. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, patient has not tested for COVID-19. The outcome of restless legs all night, felt itchy, tingly and weak when trying to walk resolved on an unknown date in Apr 2021. No follow-up attempts possible. No further information expected.

Other Meds:

Current Illness:

ID: 1811334
Sex: F
Age:
State: IA

Vax Date: 04/22/2021
Onset Date: 04/22/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Right hand significantly colder than left.; Severe pain in right shoulder blade along bottom curve.; Right arm felt like it weighed a ton; Sore throat; Sore neck; Sore back; Exhaustion; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the right arm on 22Apr2021 at 08:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included bipolar disorder, anxiety. The patient previously received hydrocodone bitartrate/paracetamol (VICODIN) on an unspecified date for an unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included lamotrigine (MANUFACTURER UNKNOWN) and ibuprofen (MANUFACTURER UNKNOWN); for unknown indications, from an unknown date and unknown if on going. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 22Apr2021 at 10:30, the patient experienced right hand significantly colder than left, felt like it had been in ice bucket, not painful but very noticeable to the touch. The condition had improved but not resolved. The patient also experienced severe pain in right shoulder blade along bottom curve, which was not improved. The patient's right arm felt like it weighed a ton on 1st day, which was resolved. The patient's joint pain both knees, right hip, right shoulder, both elbows, right wrist was not improved, sore throat, neck and back was not improved, exhaustion was resolved. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events right arm felt like it weighed a ton and exhaustion was recovered on an unknown date in Apr2021. The clinical outcome of the events right hand significantly colder than left was recovering; whereas severe pain in right shoulder blade, joint pain both knees, right hip, right shoulder, both elbows, right wrist and sore throat, neck and back was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LAMOTRIGINE; IBUPROFEN

Current Illness:

ID: 1811335
Sex: F
Age:
State: OH

Vax Date: 04/21/2021
Onset Date: 04/21/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Fever; Chills; Nausea; Multiple vomiting incidents; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the right arm on 21Apr2021 at 08:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient had no known allergies. Concomitant medications included ascorbic acid (VITAMIN C) and vitamin d nos (MANUFACTURER UNKNOWN); both for unknown indications from unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the right arm on 31Mar2021 at 08:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 20:30, the patient experienced fever, chills, nausea and multiple vomiting incidents. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills, nausea and multiple vomiting incidents was resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: VITAMIN C [ASCORBIC ACID]; VITAMIN D NOS

Current Illness:

ID: 1811336
Sex: M
Age:
State: CA

Vax Date: 04/21/2021
Onset Date: 04/21/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210419; Test Name: SARS-CoV-2 test; Test Result: Negative; Comments: Saliva.

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Chronic chest pain. Also sharp stabbing pain from left leg all the way to the chest. Chronic chest pain. Also sharp stabbing pain from left leg all the way to the chest; Dose 1 was on 03Apr2021 and Dose 2 was on 21Apr2021; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 21Apr2021 at 14:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 03Apr2021 at 01:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 17:30, the patient experienced chronic chest pain and sharp stabbing pain from left leg all the way to the chest. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had been tested for COVID-19. On 19Apr2021, the patient underwent SARS-CoV-2 test (Saliva) and the result was negative. It was unknown if therapeutic measures were taken as a result of the events. The clinical outcome of the events chronic chest pain and sharp stabbing pain from left leg all the way to the chest were unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811337
Sex: F
Age:
State: PA

Vax Date: 04/21/2021
Onset Date: 04/21/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: About 20 minutes after the vaccination, my arms were tingling; my throat closed up; Trouble swallowing; Trouble breathing; My legs were weak; my arm was sore; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0150) via an unspecified route of administration in the arm left on 21Apr2021 at 16:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included chronic Lyme disease and sulfonamide allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included imipramine hydrochloride (TOFRANIL) received within two weeks of vaccination. On 21Apr2021 at 17:00, about 20 minutes after the vaccination, the patient experienced her arms were tingling, throat closed up and she had trouble swallowing and breathing. Her legs were weak. Went to the ER and registered, waited an hour and left. By that time her arm was sore, but other symptoms were better. The events resulted in emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events arms were tingling, throat closed up, trouble swallowing, trouble breathing, legs were weak and arm was sore were resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: TOFRANIL

Current Illness:

ID: 1811338
Sex: F
Age:
State: PA

Vax Date: 04/18/2021
Onset Date: 04/18/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Fever; Chills; Headache; Loss of energy; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0162) via an unspecified route of administration in the left arm on 18Apr2021 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history (also reported as not applicable). The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8733) via an unspecified route of administration in the left arm on 28Mar2021 at 11:00 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. On 18Apr2021 at 23:00, the patient experienced fever, chills, headache and loss of energy. The events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were taken as a result of the adverse events and included treatment with TYLENOL from an unknown date. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills, headache and loss of energy were recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811339
Sex: F
Age:
State: VA

Vax Date: 04/20/2021
Onset Date: 04/21/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Felt dizzy; Headache; Felt nauseous; Body ached all over; Fatigued; Got a fever in the middle of the day for an hour or two; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 20Apr2021 at 17:45 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy, sulfonamide allergy, traumatic arthritis, nerve pain, migraine and insomnia. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included meloxicam (MANUFACTURER UNKNOWN), gabapentin (MANUFACTURER UNKNOWN), suvorexant (BELSOMRA), topiramate (MANUFACTURER UNKNOWN) and escitalopram oxalate (LEXAPRO); all on an unknown date, for unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 30Mar2021 at 17:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. On 21Apr2021 at 07:00, after 2nd dose, the patient felt dizzy, had a headache, felt nauseous, her body ached all over. She also got fever in the middle of the day for an hour or two. She was also fatigued. The next day she was still little achy, fatigued and nauseous but was feeling lot better. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events felt dizzy, headache, fever was recovered on an unknown date in Apr2021 whereas, body ached all over, felt nauseous, fatigued was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: MELOXICAM; GABAPENTIN; BELSOMRA; TOPIRAMATE; LEXAPRO

Current Illness:

ID: 1811340
Sex: M
Age:
State:

Vax Date: 04/05/2021
Onset Date: 04/06/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data: Test Date: 20210408; Test Name: PCR test; Test Result: Negative ; Comments: Nasal swab

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Entire body morbilliform rash primarily on ribs and stomach, spreading slowly to upper arms. Not painful but mildly itchy; Entire body morbilliform rash primarily on ribs and stomach, spreading slowly to upper arms. Not painful but mildly itchy; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the right arm on 05Apr2021 at 11:45 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On 06Apr2021, the patient experienced entire body morbilliform rash primarily on ribs and stomach, spreading slowly to upper arms. It was not painful but mildly itchy. It was reported that it had been 14 days now (at the time of this report) and spread had slowed but was not receding much, only a little bit around neck had gone away. Slightly lighter in color now all over. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events as the patient had been using over the counter 1 percent hydrocortisone creme twice a day for 4 days. On 08Apr2021, the patient underwent PCR test for COVID-19 via nasal swab and the result was negative. The clinical outcome of the events entire body morbilliform rash primarily on ribs and stomach, spreading slowly to upper arms. Not painful but mildly itchy was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811341
Sex: M
Age:
State: CO

Vax Date: 04/23/2021
Onset Date: 04/23/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Left ear sounds muffled/ right ear has definite less hearing than left; Right ear mild ringing; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old, male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in right arm on 23Apr2021 at 14:00 (at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to avocados. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Apr2021 at 16:00, the patient experienced right ear mild ringing after 2 hours of injection. On 24Apr2021, the left ear sounded muffled like he had water in there. This started when he woke up the morning. The patient tried to get his ear to pop by driving up a high mountain and coming down (12,000 feet elevation) however he could feel it trying to pop but did not. The right ear had definite less hearing than left and was extremely noticeable. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events of right ear mild ringing and left ear sounds muffled, right ear has definite less hearing than left was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811342
Sex: F
Age:
State:

Vax Date: 04/19/2021
Onset Date: 04/20/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Severe body aches in back & legs; Severe body aches in back; Headache; Loss of appetite; Fever; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 19Apr2021 at 16:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included celiac disease and allergy to gluten. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included medication for birth control (unspecified) and montelukast sodium (SINGULAIR); both from unknown dates, for unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 22Mar2021 at 15:30 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Apr2021 at 11:00, the patient experienced severe body aches in back and legs, headache, loss of appetite, fever and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe body aches in back, severe body aches in legs, headache, loss of appetite, fever and fatigue was unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: SINGULAIR.

Current Illness:

ID: 1811343
Sex: F
Age:
State: NC

Vax Date: 04/15/2021
Onset Date: 04/16/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Thyroid/throat area swelling; Shortness of breath; Tingling in arms and legs; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 15Apr2021 at 18:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included Hashimoto's disease, celiac disease and allergies included gluten sensitivity. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included thyroid (ARMOUR THYROID) and naloxone hydrochloride, buprenorphine hydrochloride (SUBOXONE) from an unknown date for an unknown indication and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 23Mar2021 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 16Apr2021, shortness of breath began approximately 24 hours after second dose of vaccine and was continuing up to date. Tingling in arms and legs began approximately 24 hours after vaccine and was continuing to date. On 16Apr2021 at 18:15, 24 hours after vaccine patient experienced thyroid/throat area swelling and was continuing to date. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events shortness of breath, tingling in arms and legs and thyroid/throat area swelling was recovering at the time of report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ARMOUR THYROID;

Current Illness:

ID: 1811344
Sex: F
Age:
State: MD

Vax Date: 04/22/2021
Onset Date: 04/23/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Mouth sores; Red bumps all over body; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 22Apr2021 at 10:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation. On 23Apr2021, the patient experienced mouth sores and red bumps all over body. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events mouth sores and red bumps all over body were resolving at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811345
Sex: F
Age:
State: NY

Vax Date: 04/22/2021
Onset Date: 04/23/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Fever; Chills; Nausea; Tiredness; Body-aches/Soreness; Small red rash near injection site; Persistent Headache; Dehydration; This is a spontaneous report received from a contactable consumer, the patient. A 31-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO175) via an unspecified route of administration in the left arm on 22Apr2021 at 10:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included VITMAIN D deficiency and allergy to PENICILLIN. It was unknown if the patient was pregnant. Concomitant medications included VITMAIN D 50000 MG. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO150) via an unspecified route of administration in the left arm on 01Apr2021 at 16:30 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. On 23Apr2021 at 21:00, the patient experienced fever, chills, nausea, tiredness, body-aches, soreness, small red rash near injection site, persistent headache, and dehydration. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, chills, nausea, tiredness, body-aches, soreness, small red rash near injection site, persistent headache, and dehydration was resolved with sequelae (also reported as recovered with lasting effects) on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: VITAMIN D

Current Illness:

ID: 1811346
Sex: F
Age:
State: PA

Vax Date: 04/10/2021
Onset Date: 04/11/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210414; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Negative

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: I got a mild skin rash on my chest, but it wasn't really itchy; my arm swelled a little and was very tender; Chills; headache; body aches/pains; extreme fatigue; had limited range of motion; shoulder and arm pain; shoulder and arm pain; shooting pain; This is a spontaneous report from a contactable consumer or other non hcp. A 47-years-old female non Pregnant patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection (Batch/Lot Number: ER8731), dose 2 via an unspecified route of administration, administered in Arm Left on 10Apr2021 11:30 as 2nd dose, single for covid-19 immunisation. Medical history included ongoing Multiple sclerosis. Concomitant medication(s) included natalizumab (TYSABRI); melatonin (MELATONIN); zolpidem tartrate (AMBIEN. The patient previously took bnt162b2 for covid-19 immunisation, tetracycline. The patient did not receive any other vaccine in four weeks. Prior to vaccination patient was not diagnosed with COVID. Post vaccination patient did not test for COVID It was Reported that, on 11 Apr2021 07:00 evening after she received the vaccine, my arm swelled a little and was very tender.The next morning, woke up and felt minor chills, headache, body aches/pains and extreme fatigue. This continued for two days. Two days after the vaccine got a mild skin rash on my chest, but it wasn't really itchy.It went away less than 24 hours later. By the third day after was only fatigued. Day 4 or 5 I was back to normal, had limited range of motion, shoulder and arm pain, shooting pain when I move it in certain directions. The outcome of the event was not recovered. The patient underwent lab tests and procedures which included sars-cov-1 test negative: negative on 14Apr2021. Therapeutic measures were taken as a result of Physical Therapy, had limited range of motion (joint range of motion decreased), shoulder and arm pain (arthralgia), shoulder and arm pain (pain in extremity), shooting pain (pain). Follow-Up (08Jul2021): Follow-up attempts are completed. No further information is expected.

Other Meds: TYSABRI; MELATONIN; AMBIEN

Current Illness:

ID: 1811347
Sex: F
Age:
State: TX

Vax Date: 03/24/2021
Onset Date: 03/24/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210324; Test Name: Body temperature; Result Unstructured Data: Test Result:101 Units:[degF]; Comments: 101F

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Headache; Start of mild signs random located rash/rash become severe on face and neck /rash moved and severely affected my back; soreness in neck and upper back; intense sore ness in neck; Intense fatigue; Ache than a sharp pain; First night - 101F fever. After Second night in the morning: Intense soreness in neck and upper back in the morning. I had to stay laying down. The pain was more of an intense fatigue and ache than a; This is a spontaneous report from a contactable consumer, the patient. A 24-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER7534) via an unspecified route of administration in the right arm on 24Mar2021 at 09:45 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included herbal allergy medication (MANUFACTURER UNKNOWN) from an unknown date for unknown indication and unknown if ongoing. On 24Mar2021 at 23:45, first night after vaccination, the patient experienced 101F fever. On 26Mar2021, after second night in the morning: intense soreness in neck and upper back in the morning, the patient had to stay laying down. The pain was more of an intense fatigue and ache than a sharp pain. Start of mild signs random located rash. On, third day: alright for the most part. On 27Mar2021, fourth day: morning, the sharper type of sore in neck and back after waking. Intense, midday headache. Evening, rash become severe on face and neck. On fifth day evening: Rash severe on face. After ointment applied on face, rash moved and severely affected my back. After applying more ointment, rash moved again. However, applying more medication has helped. On fifth day: rash still present all over face, neck, and head but not as itchy. (It is the fifth day today). On 24Mar2021, the patient underwent body temperature test and the result was 101 degrees Fahrenheit. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events rash on head, face and neck which included treatment with ointment and medication (unspecified). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events, 101F fever, intense soreness in neck and upper back, intense fatigue and ache, mild signs random located rash, sharper type of sore in neck and back after waking, intense, midday headache, rash become severe on face and neck, rash severe on face, rash moved and severely affected back, rash still present all over face, neck, and head but not as itchy was recovering at the time of this report. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729,) via an unspecified route of administration in the left arm on 14Apr2021 at 09:45 (at the age of 24-year-old) as a single dose for COVID-19 immunisation. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811348
Sex: F
Age:
State: FL

Vax Date: 04/23/2021
Onset Date: 04/24/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210424; Test Name: Body temperature test; Result Unstructured Data: Test Result:99.5

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Severe chills; Fever 99.5; Severe headache; Skin hurt; Dehydration; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 23Apr2021 at 11:45 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy (sulfa type antibiotics) and penicillin allergy (PCN antibiotic). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication was not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Apr2021 at 02:00, 14 hours after 2nd dose, the patient experienced severe chills, fever 99.5, severe headache, skin hurt and dehydration. On the same day, the patient underwent a body temperature test and the result was 99.5 (UNSPECIFIED UNITS). The events did not result in doctor or other healthcare professional office/clinic visits, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe chills, fever 99.5, severe headache, skin hurt and dehydration was recovered on 24Apr2021 at 17:00, after the duration of 15 hours. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811349
Sex: M
Age:
State: NJ

Vax Date: 03/25/2021
Onset Date: 04/04/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Mild headache and extreme difficulty mentally focusing at 5 days and counting.; extreme difficulty mentally focusing at 5 days and counting. This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the right arm on 25Mar2021 at 11:15 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks of vaccination. The patient previously received loratadine (CLARITIN) on an unknown date and experienced allergy. On 04Apr2021 at 22:00, the patient experienced mild headache and extreme difficulty in mentally focusing at 5 days and counting. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room or department/urgent care. Therapeutic measures were not taken as a result of reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events mild headache and extreme difficulty in mentally focusing was not recovered at the time of this report. The patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on 15Apr2021 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811350
Sex: F
Age:
State: NJ

Vax Date: 04/21/2021
Onset Date: 04/22/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Nose becomes very itchy; Have thousands of sneeze, uncontrollable sneezes.; Feel a little of itchy eyes; Couldn't sleep well at night because of the itchy nose; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 21Apr2021 at 09:15 at the age of 37-years-old as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 22Apr2021, the patient's nose became very itchy and had thousands of sneezes, uncontrollable sneezes. The patient also felt a little of itchy eyes and couldn't sleep well at night because of the itchy nose. The patient never had any allergic reaction in life before. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events nose became very itchy, thousands of sneeze uncontrollable sneezes, itchy eyes and couldn't sleep well at night because of the itchy nose was not recovered at the time of this report. No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1811351
Sex: F
Age:
State: CO

Vax Date: 04/18/2021
Onset Date: 04/19/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Period starts 5 days early; Abdominal cramping; Sneezing constantly; Dry but runny nose/ moderate runny nose/ mild runny nose; Mild cough; Dry but runny eyes/ moderate runny eyes/ mild runny eyes; Rash on hands, face, and chest; 7-10 episodes of vomiting; Moderate fatigue /extremely fatigued; Frequent diarrhea/ moderate diarrhea; Mild nausea / severe nausea /moderate nausea; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the right arm on 18Apr2021 at 14:00 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history includes bipolar 1, attention deficit-hyperactivity disorder (ADHD), anxiety, post-traumatic stress disorder (PTSD), arthritis, asthma, psoriasis, COVID-19, allergic to cats and certain food colorings if ingested. Prior to vaccination, the patient was diagnosed with COVID-19. Concomitant medications included lithium carbonate (MANUFACTURER UNKNOWN), quetiapine fumarate (SEROQUEL), lisdexamfetamine mesilate (VYVANSE) and hydroxyzine (MANUFACTURER UNKNOWN); all for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to vaccination. On 19Apr2021 at 17:30, day 1, the patient experienced moderate fatigue, frequent diarrhea and mild nausea. On 20Apr2021, day 2-4, the patient experienced sneezing constantly, dry but runny eyes and nose, mild cough, extremely fatigued, rash on hands, face, and chest, frequent diarrhea, 7- 10 episodes of vomiting, severe nausea and no soreness. On 23Apr2021,day 5, the patient had abdominal cramping, moderate runny nose and eyes, sneezing, moderate nausea and frequent diarrhea. On 24Apr2021, day 6, the period started 5 days early and experienced extremely fatigued, no sneezing, mild runny eyes and nose, no nausea and moderate diarrhea. The patient did not have any swelling or soreness and reported that vaccine was painless. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events moderate fatigue, frequent diarrhea, mild nausea, sneezing constantly, dry but runny eyes and nose, mild cough, extremely fatigued, rash on hands, face, and chest, 7- 10 episodes of vomiting, severe nausea, abdominal cramping, moderate runny nose and eyes, moderate nausea and period started 5 days early was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LITHIUM CARBONATE; SEROQUEL; VYVANSE; HYDROXYZINE

Current Illness:

ID: 1811352
Sex: F
Age:
State: PA

Vax Date:
Onset Date: 04/24/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Severe Arm soreness; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. Medical history and concomitant medication were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Apr2021 at 12:00 the patient experienced severe arm soreness. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe arm soreness was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811353
Sex: F
Age:
State: NC

Vax Date: 04/19/2021
Onset Date: 04/19/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Tongue started swelling; This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the right arm on 19Apr2021 (at the age of 62-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified blood pressure meds (MANUFACTURE UNKNOWN) for unspecified indications, from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 19Apr2021, the patient experienced tongue started swelling and white welms occurred 2 hours after vaccine was administered. Since the vaccination, it was unknown if the patient was tested for COVID-19. Therapeutic measures were taken as a result of event tongue started swelling and white welms which included diphenhydramine hydrochloride (BENADRYL) from on unknown date. The clinical outcome of the events Tongue started swelling and white welms were recovering at the time of report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1811354
Sex: F
Age:
State: HI

Vax Date: 04/03/2021
Onset Date: 04/04/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Menstruation began the next day after the vaccine was administered. It was 2 weeks early.; Period was extremely heavy/It lasted for 14 days; Headache; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: BP7533) via an unspecified route of administration in the left arm on 03Apr2021 at 10:00 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included thyroid cancer on 2006 and unknown if ongoing. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included birth control pills (MANUFACTURER UNKNOWN) taken for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 10:00, the next day after the vaccination, the patient experienced menstruation which was 2 weeks early. Her cycle was regulated by birth control pills so it was always regular where vaccine started her period the way the placebo pill does on her birth control pills. Her period was extremely heavy and never had heavy bleeding prior to the vaccine. It lasted for 14 days whereas her regular period was light and lasts 3-4 days. She had a headache for 7 days and 7th day her headache was so extreme that she was about to go to the Emergency Room but she was worried about the costs of the ER so she didn't go. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event menstruation began the next day after the vaccine was administered and 2 weeks early and extremely heavy period was recovered on 18Apr2021. The clinical outcome of the event headache was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811355
Sex: M
Age:
State:

Vax Date: 04/23/2021
Onset Date: 04/23/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Flu like symptoms the day after; Very sore arm; Joint aches; Uncontrollable shaking for a couplehours; Fever; Chills; This is a spontaneous report from a non-contactable consumer, the patient. A 29-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the right arm on 23Apr2021 at 09:00 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included unspecified over the counter allergy medicine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 02Apr2021 at 08:30 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. On 23Apr2021 at 20:00, the patient experienced very sore arm, joint aches, uncontrollable shaking for a couple of hours, fever and chills. On 24Apr2021 (reported as the day after), the patient experienced flu like symptoms. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events very sore arm, joint aches, uncontrollable shaking for a couple of hours, fever, chills and flu like symptoms was resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1811356
Sex: F
Age:
State: OH

Vax Date: 04/22/2021
Onset Date: 04/23/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Swollen and painful lymph node near collarbone; Swollen and painful lymph node near collarbone; Achy joints; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the right arm on 22Apr2021 at 14:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included seasonal allergies and sports induced asthma. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the right arm on 01Apr2021 at 15:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Apr2021 at 07:30, the patient experienced swollen and painful lymph node near collarbone and achy joints. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swollen and painful lymph node near collarbone and achy joints were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811357
Sex: F
Age:
State:

Vax Date: 01/09/2020
Onset Date: 04/01/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: pain and swelling in her fingers and toes; pain and swelling in her fingers and toes; having a bad flare a week after getting first covid vaccine; This is a spontaneous report from a contactable other hcp (clinician). A 53-year-old female patient received bnt162b2 (BNT162B2 formulation; Solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient received tofacitinib citrate (XELJANZ XR Prolonged-release tablet), oral from 09Jan2020 (Batch/Lot number was not reported) and ongoing, at 11 mg, daily for rheumatoid arthritis. Medical history included rheumatoid arthritis from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient experienced pain and swelling in her fingers and toes and bad flare a week after getting first covid vaccine on an unknown date of Apr2021. Xeljanz was not held during this time. It was reported that MD was aware. The patient prescribed prednisone to help relieve the swelling and pain. The patient would wait a week or two before getting the second vaccine. Therapeutic measures were taken as a result of pain and swelling in her fingers and toes. The action taken in response to the events for tofacitinib citrate was dose not changed. The outcome of event was unknown. No follow-up attempts are needed. Information about lot/batch number cannot be obtained.

Other Meds: Xeljanz XR

Current Illness:

ID: 1811358
Sex: F
Age:
State: FL

Vax Date: 04/17/2021
Onset Date: 04/21/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Extreme fatigue on day 6-7; Slept 14 hours; Itchy raised rash on chest and arms starting approximately 4-5 days after vaccine; Extreme itching, it woke me up in the middle of the night; This is a spontaneous report from a contactable nurse, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration on 17Apr2021 at 14:30 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included history of cancer. The patient had known allergy to radiography dye. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included resveratrol (MANUFACTURER UNKNOWN), NMN and berberine (MANUFACTURER UNKNOWN); all taken for unknown indications from an unknown date and unknown if ongoing. On 21Apr2021 at 03:00, approximately 4-5 days after vaccine, the patient experienced itchy raised rash on chest and arms. The patient had extreme itching, it woke her up in the middle of the night. On 23Apr2021, 6-7 day after vaccine, the patient experienced extreme fatigue and slept 14 hours. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events itchy raised rash on chest and arms starting approximately 4-5 days after vaccine, extreme itching, it woke her up in the middle of the night, extreme fatigue on day 6-7 and slept 14 hours were not recovered at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: RESVERATROL; BERBERINE

Current Illness:

ID: 1811359
Sex: M
Age:
State: IL

Vax Date: 04/23/2021
Onset Date: 04/23/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Sore throat 12 hours after injection; Cough 12 hours after injection; Chills; Dizziness; Weakness10 minutes after injection.; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 23Apr2021 at 09:45 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and diabetes. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included atenolol (MANUFACTURER UNKNOWN), glimepiride (MANUFACTURER UNKNOWN), famotidine (MANUFACTURER UNKNOWN), retinol (VITAMIN A), vitamin b complex (VITAMIN B) and ascorbic acid (VITAMIN C); all for unknown indication from unknown date and unknown if ongoing. The patient previously took citric acid (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date and experienced drug allergy. On 23Apr2021 at 09:55, the patient experienced chills, dizziness, weakness 10 minutes after injection and sore throat, cough 12 hours after injection. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event chills, dizziness, weakness, sore throat and cough was not recovered at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ATENOLOL; GLIMEPIRIDE; FAMOTIDINE; VITAMIN A [RETINOL]; VITAMIN B [VITAMIN B COMPLEX]; VITAMIN C [ASCORBIC ACID]

Current Illness:

ID: 1811360
Sex: F
Age:
State: MD

Vax Date: 04/19/2021
Onset Date: 04/21/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Broke out with a bumpy rash all over chest and face (cheeks, chin area).; Almost looks like clogged pores or acne but was not there prior.; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 19Apr2021 at 11:30 as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and mild autoimmune. The patient had a history of allergy to peanuts, pine nuts, avocado, penicillin and sulfa drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), ammonium chloride, diphenhydramine hydrochloride, menthol, sodium citrate (BENADRYL) and lifitegrast (XIIDRA) eyedrops; all from unknown date for unknown indication and unknown if ongoing. The patient previously took cefaclor (CECLOR) and experienced drug allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 25Mar2021 at 11:00 as a single dose for COVID-19 immunisation. On 21Apr2021 at 21:00, the patient experienced broke out with a bumpy rash all over my chest and face (cheeks, chin area) which was almost looks like clogged pores or acne but was not there prior. It was slowly subsiding but still present five days later. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events broke out with a bumpy rash all over chest and face (cheeks, chin area) and almost looks like clogged pores or acne but was not there prior was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXINE; BENADRYL; XIIDRA

Current Illness:

ID: 1811361
Sex: F
Age:
State: TN

Vax Date: 04/24/2021
Onset Date: 04/24/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Swelling of the eyebrows; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 24Apr2021 at 16:45 (at the age of 67-year-old), as a single dose for COVID-19 immunisation. Medical history included high blood pressure and known allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN) 10mg for unknown indication from an unknown date and unknown if ongoing. On 24Apr2021 at 20:45, the patient experienced swelling of the eyebrows. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swelling of the eyebrows was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: AMLODIPINE

Current Illness:

ID: 1811362
Sex: F
Age:
State: CA

Vax Date: 04/19/2021
Onset Date: 04/19/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data: Test Date: 20210419; Test Name: Body temperature; Result Unstructured Data: Test Result:fever of 101

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Redness in injection site; Itchiness in injection site; Minor swelling in injection site; Severe body aches while on antiinflammatorymeds; fever of 101 while on meds; Skin hurt like needles stabbing; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number: Er8735) via an unspecified route of administration in the left arm on 19Apr2021 at 09:15 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included allergic to walnuts and cough medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included cetirizine hydrochloride (ZYRTEC) and budesonide (NASOCORT); both for an unknown indication from an unknown date and unknown if ongoing. The patient previously received some antifungal medications, miconazole nitrate (MONISTAT) and lidocaine (VAGISIL) for an unknown indication from an unknown date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er8732) via an unspecified route of administration in the left arm on 29Mar2021 at 09:15 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. On 19Apr2021, the patient experienced severe body aches while on anti-inflammatory medicines, fever of 101 while on medicines, skin hurt like needles stabbing all started about 3 hours after injection and lasted for about 36 hours. On 23Apr2021, 4 days after the injection, the patient experienced redness, itchiness and minor swelling in injection site. Swelling and redness lasted for about 24 hours. On 19Apr2021, the patient underwent lab tests and procedures which included body temperature test and the result was found to be 101 (unspecified units). The events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures taken as a result of the reported events severe body aches included treatment with anti-inflammatory medicines and the treatment for fever included unspecified medicines. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe body aches, fever, skin hurt like needles stabbing were recovered on an unknown date in Apr2021 which lasted for about 36 hours, while the events minor swelling and redness in injection site were recovered on an unknown date in Apr2021 which lasted about 24 hours and the event itchiness at the injection site was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ZYRTEC [CETIRIZINE HYDROCHLORIDE]; NASOCORT

Current Illness:

ID: 1811363
Sex: M
Age:
State: MO

Vax Date: 04/14/2021
Onset Date: 04/17/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Hurting joints in my knees and especially in my hands when i grip things; Hands feel swollen but don't look swollen; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 14Apr2021 at 12:15 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included minor anxiety. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included fluoxetine (MANUFACTURER UNKNOWN); taken for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 17Mar2021 at 12:15 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. On 17Apr2021 at 12:00, the patient had hurting joints in his knees and especially in his hands when he grips things. Hands felt swollen but did not look swollen. Onset was within a few days of the second dose and seemed to be getting worse instead of better. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events hurting joints in knees and especially in hands when he grips things and hands felt swollen but did not look swollen was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: FLUOXETINE

Current Illness:

ID: 1811364
Sex: M
Age:
State: VA

Vax Date: 04/02/2021
Onset Date: 04/02/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Chills/heat flash 16+ hours after shot.; Chills/heat flash 16+ hours after shot.; Low grade fever, body/joint pains onset +12 hours after shot; Low grade fever, body/joint pains onset +12 hours after shot; Low grade fever, body/joint pains onset +12 hours after shot.; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 02Apr2021 at 08:15 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included inappropriate sinus tachycardia. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 20:15, the patient experienced low grade fever, body pains, joint pains with onset of plus 12 hours after shot. The patient also experienced chills, heat flash 16 plus hours after shot on 03Apr2021. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events low grade fever, chills, heat flash was resolved on an unknown date in Apr2021 plus 24 hours after shot, while that of body pains, joint pains was resolved on an unknown date in Apr2021 plus 36 hours after shot. The patient also received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 23Apr2021 at 08:15 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811365
Sex: F
Age:
State: CO

Vax Date: 04/21/2021
Onset Date: 04/22/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Extreme redness, warm, tenderness and allodynia type response starting at the puncture site and spreading 4 to 7 mm out across.; Extreme redness, warm, tenderness and allodynia type response starting at the puncture site and spreading 4 to 7 mm out across.; Extreme redness, warm, tenderness and allodynia type response starting at the puncture site and spreading 4 to 7 mm out across.; Extreme redness, warm, tenderness and allodynia type response starting at the puncture site and spreading 4 to 7 mm out across.; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 21Apr2021 at 10:00 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies. Prior to vaccination, the patient was diagnosed with COVID-19. Concomitant medications included estradiol (MANUFACTURER UNKNOWN), medroxyprogesterone (MANUFACTURER UNKNOWN), zinc (MANUFACTURER UNKNOWN), ergocalciferol (VIT D) and azithromycin (Z-PAK); all from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 31Mar2021 at 10:45 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. On 22Apr2021 at 18:30, the patient experienced COVID arm extreme redness, warm, tenderness and allodynia type response starting at the puncture site and spreading 4 to 7 mm out across. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events extreme redness, warm, tenderness and allodynia type response were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ESTRADIOL; MEDROXYPROGESTERONE; ZINC; VIT D [ERGOCALCIFEROL]; Z-PAK

Current Illness:

ID: 1811366
Sex: F
Age:
State: MN

Vax Date: 04/17/2021
Onset Date: 04/24/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Intense flare up of my arthritis in my entire arm; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm on 17Apr2021 at 16:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included inflammatory arthritis and known allergy to MRI dye. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included duloxetine hydrochloride (CYMBALTA) for unknown indication from an unknown date and unknown if ongoing. The patient has been in remission from inflammatory arthritis for 2 years and on 24Apr2021 at 21:00, the patient had an acute but intense flare up of arthritis in entire arm, the same arm vaccine was in. It lasted around 12 hours. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event "intense flare up of my arthritis in my entire arm, the same arm vaccine was in" was resolved on 25Apr2021. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: CYMBALTA

Current Illness: Inflammatory arthritis (Remission from inflammatory arthritis for 2 years)

ID: 1811367
Sex: F
Age:
State: NJ

Vax Date: 03/18/2021
Onset Date: 04/03/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Feet swollen; This is a spontaneous report from a contactable consumer, the patient. A 74-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 18Mar2021 at 14:00 (at the age of 74-years-old) as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis (RA), asthma, lupus and allergy to sulfa. Concomitant medications included prednisone (MANUFACTURER UNKNOWN), gabapentin (MANUFACTURER UNKNOWN), apixaban (ELIQUIS), magnesium (MANUFACTURER UNKNOWN), calcium (MANUFACTURER UNKNOWN) and colecalciferol (VITAMIN D3): all from unknown dates for unknown indications and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 09:00 the patient experienced feet swollen. It was still swollen on 25Apr2021. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event feet swollen which included compression socks to no avail. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event feet swollen was not resolved at the time of the report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: PREDNISONE; GABAPENTIN; ELIQUIS; MAGNESIUM; CALCIUM; VITAMIN D3

Current Illness:

ID: 1811368
Sex: M
Age:
State: CA

Vax Date: 04/16/2021
Onset Date: 04/18/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: LEFT arm broke out in blistery rash from left wrist to left shoulder; All side effects were in left arm (joint + muscle pain) plus this rash; All side effects were in left arm (joint + muscle pain) plus this rash; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the right arm on 16Apr2021 at 09:45 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and high cholesterol. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient had received injection in right arm due to being left handed. On 18Apr2021, his left arm broke out in blistery rash from left wrist to left shoulder. All side effects were in left arm including joint and muscle pain plus the rash. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events left arm broke out in blistery rash from left wrist to left shoulder; all side effects were in left arm including joint and muscle pain plus the rash was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811369
Sex: F
Age:
State: NJ

Vax Date: 04/02/2021
Onset Date: 04/03/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Severe muscle soreness left hip & thigh; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 02Apr2021 at 12:45 (at the age of 47-years-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the right arm on 23Apr2021 at 12:45 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had received medication (unspecified) within two weeks of vaccination on an unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 10:00, the patient experienced severe muscle soreness in left hip and thigh. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event severe muscle soreness in left hip and thigh was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1811370
Sex: F
Age:
State: CA

Vax Date: 04/14/2021
Onset Date: 04/14/2021
Rec V Date: 10/23/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Neck and arm pain shooting down to the hand; Neck and arm pain shooting down to the hand; Severe Headaches; Twitching of left hand; Blurry vision; Fog headed; Unable to focus; Body and joint pain; Body and joint pain; Memory loss; Nausea; Vomiting; Diarrhea; This is a spontaneous report from a contactable nurse, the patient. A 37-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the left arm on 14Apr2021 at 13:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included iron chew (MANUFACTURER UNKNOWN) and vitamins (MANUFACTURER UNKNOWN), all for an unknown indication from an unknown date and unknown if ongoing. The patient previously took prochlorperazine edisylate (COMPAZINE) and metoclopramide (REGLAN) for unknown indication on an unknown date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via intramuscular route of administration in the left arm on 17Mar2021 at 13:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. On 14Apr2021 at 14:00, the patient experienced neck and arm pain shooting down to the hand, severe headaches, twitching of left hand, blurry vision, fog headed, unable to focus, body and joint pain, memory loss, nausea, vomiting and diarrhea. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The clinical outcome of the events neck and arm pain shooting down to the hand, severe headaches, twitching of left hand, blurry vision, fog headed, unable to focus, body and joint pain, memory loss, nausea, vomiting and diarrhea was not resolved at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: IRON

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am